IP Library Granted Patent US 7,625,838
Granted Patent B2
US 7,625,838 · App. 12/486,155 · Granted Dec 1, 2009

[1, 2, 4] Triazolo [1, 5-A] pyrimidine derivatives as chromatographic adsorbent for the selective adsorption of IGG

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,625,838
App. No.
12/486,155
Granted
Dec 1, 2009
Kind
B2
Abstract

The present invention relates to a chromatographic adsorbent for selectively adsorbing IgG, comprising the following formula and its corresponding enol-form, wherein X represents O, S, or NH; R 1 represents H, C 1-6 alkyl, C 1-6 alkoxy, C 1-6 alkoxy-C 1-6 alkyl, Ar, —C(O)NHR 3 , —C(O)—R 3 or halo; R 2 represents H, C 1-3 alkyl or halo; R 3 represents H, C 1-6 alkyl, C 1-6 alkoxy, C 1-6 alkoxy-C 1-6 alkyl or Ar; n represents 0, 1, 2 or 3; Y represents a carrier. The present invention also relates to a method of producing said adsorbent as well as use thereof for separating substances by affinity chromatography.

Claims (17)

1. A method for affinity chromatography, comprising the step of selectively adsorbing IgG, fragments thereof and/or complexes involving IgG or fragments thereof on a chromatographic adsorbent, using a compound comprising the following formula

and its corresponding enol-form,

wherein

X represents O, S, or NH;

R 1 represents H, C 1-6 alkyl, C 1-6 alkoxy, C 1-6 alkoxy-C 1-6 alkyl, Ar, —C(O)NHR 3 , —C(O)—R 3 or halo;

R 2 represents H, C 1-3 alkyl or halo;

R 3 represents H, C 1-6 alkyl, C 1-6 alkoxy, C 1-6 alkoxy-C 1-6 alkyl or Ar;

n represents 0, 1, 2 or 3;

Y represents a carrier;

Ar represents a C 6-10 aryl group, which group is optionally substituted by one or more substituents selected from —OH, cyano, halo, nitro, C 1-6 alkyl and alkoxy.

2. The method of claim 1 , wherein the carrier Y is selected from cellulose, starch, dextran, agar, agarose, polyacrylamide, poly(meth)acrylate, a polyvinyl hydrophilic polymer, polystyrene and polysulfone, silica, alumina, titania oxide, zirconia oxide, a polysaccharide-synthetic polymer, a polysaccharide-mineral structure, or a synthetic polymer-mineral structure.

3. The method of claim 1 , wherein R 1 represents H, n represents 0, X represents NH and Y represents agarose.

4. The method of claim 3 , further comprising a spacer molecule between X and Y.

5. The method of claim 4 , wherein Y represents HP-Sepharose, and hexamethylene diamine is the spacer molecule.

6. The method of claim 1 , further comprising a spacer molecule between X and Y.

7. The method of claim 6 , wherein R 1 represents H, n represents 0, X represents NH, Y represents HP-Sepharose, and hexamethylene diamine is the spacer molecule.

8. The method of claim 1 , wherein the carrier material Y is in the form of beads, irregularly shaped particles, fibers, membranes, flat structure or porous mineral materials.

Assignments (2)
CHANGE OF NAME Recorded Oct 5, 2020
From: GE HEALTHCARE BIOPROCESS R&D AB
To: CYTIVA BIOPROCESS R&D AB
Reel/Frame 054299/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2016
From: GE HEALTHCARE BIO-SCIENCES AB
To: GE HEALTHCARE BIOPROCESS R&D AB
Reel/Frame 038811/0001 →